Genome-wide association studies (GWAS) have uncovered many genetic risk loci for psoriasis, 31 yet many remain uncharacterised in terms of the causal gene and their biological mechanism in 32 disease. Here, we use a disease-focused Capture Hi-C experiment to link psoriasis-associated 33 variants with their target genes in psoriasis-relevant cell lines (HaCaT keratinocytes and My-La CD8+ 34 T cells). We confirm previously assigned genes, suggest novel candidates and provide evidence for 35 complexity at psoriasis GWAS loci. In the 9q31 risk locus we combine further epigenomic evidence to 36 demonstrate how the psoriasis association forms a functional interaction with the distant (>500 kb) 37 KLF4 gene. We use CRISPR activation coupled with RNA-seq to demonstrate how activation of 38 psoriasis-associated enhancers upregulates KLF4 in HaCaT cells. Our study design provides a robust 39 pipeline for following up on GWAS disease-associated variants, paving the way for functional 40 translation of genetic findings into clinical benefit. 41 5 translocated loci in My-La cells (Netchiporouk et al., 2017). In light of this, the interactions were 91 filtered to only include cis (same-chromosome) interactions.
Introduction 42
Psoriasis is an immune-mediated condition affecting around 2% of the worldwide population 43 (Griffiths and Barker, 2007) . Psoriasis usually manifests as red, scaly plaques on the skin and is 8 however, the interactions did not coincide with the fragment containing the gene itself.
164
Furthermore, KLF4 expression was not detected by RNA-seq in My-La cells, suggesting a cell-type 165 specific mechanism. In all cell types, long-range interactions also stretched from the psoriasis locus 166 to the telomeric side of the gene desert but fell short of the nearest gene on that side (ACTL7B) by 167 approximately 35 kb.
168
At the 5p13.1 locus, the psoriasis SNPs are similarly intergenic (Tsoi et al., 2015) but the nearest 169 gene PTGER4 has been shown to be a strong candidate for other autoimmune diseases at this locus 170 (Mumbach et al., 2017) . Our CHi-C data showed interactions (CHiCAGO score ≥ 5) between multiple 171 psoriasis-associated fragments and PTGER4 over approximately 300 kb to the other end of the TAD; 172 a finding that was robust in all cell types ( Figure 1B) . PTGER4 expression was detected by RNA-seq in 173 all cell types ( Supplementary Table 5 ). In My-La cells, interactions also stretched to the promoters of 174 TTC33, which was expressed in all cell types, and RPL37, for which expression was not detected in (Figure 2A ) (Maine et al., 2007 , 191 Tsoi et al., 2012 . This interaction occurred in stimulated HaCaT cells and My-La cells, and COMMD1 192 expression was detected by RNA-seq in all cell types ( Supplementary Table 5 ). B3GNT2 expression 193 was also detected in all cell types (data not shown).
194
At the 1p36.23 locus, the association tagged by rs11121129 is closest to SLC45A1, and was 195 originally assigned to multiple putative gene targets (Tsoi et al., 2012) . However, the CHi-C data 196 showed interactions (CHiCAGO score ≥ 5) between the psoriasis LD block and the promoter of ERBB 244 We focused our attention on the large intergenic locus at 9q31, tagged by rs10979182 , which 245 showed long-range interactions between the psoriasis-associated SNPs and KLF4 ( Figure 1A) 
291
Restricting the significant H3K27ac-mediated interactions to those originating from the psoriasis-292 associated enhancers in HaCaT cells revealed multiple enhancer-enhancer interactions in 9q31.
293
However, other than KLF4 there were no other gene targets implicated by H3K27ac-mediated HiChIP
294
interactions in 9q31 (data not shown).
295
We observed an increase in the number and strength of H3K27ac peaks in the 9q31 TAD (chr9:110,202,281-111,602,280) 
296

3C-qPCR supplemented HiChIP/CHi-C findings in the 9q31 locus 318
We used 3C-qPCR in an effort to confirm the interaction between the psoriasis-associated 319 putative enhancer 3 (rs6477612) and KLF4 to further prioritise regulatory SNPs. Our 3C experiment 320 utilised both the enhancer and the KLF4 gene as focus anchors, in both HaCaT and My-La cell lines.
321
The enhancer-focused 3C experiment identified interaction peaks with regions approximately 2.5kb 
18
The KLF4-focused 3C experiment showed that KLF4 significantly interacted with several 325 intergenic psoriasis-associated fragments, including the fragment containing the third putative 326 enhancer (rs6477612), in HaCaT cells, but not in My-La cells ( Supplementary Figure 4 ). This 327 corroborates the CHi-C data, which showed a more robust interaction between the enhancer and 
331
Taken together, the 3C results confirm a close spatial proximity between the psoriasis-associated 332 SNPs and KLF4 in 9q31. However, there is no clear peak of interaction among the LD block that Figure 6B ).
337
ChIP-qPCR confirmed binding of regulatory histone marks in 9q31 in HaCaT cells
19
To determine potential effects of the risk or protective allele of rs6477612, the most likely 349 regulatory SNP within enhancer 3, we performed allele-specific ChIP at rs6477612 for H3K4me1 and
350
H3K27ac in two pools of NHEK cells. However, there was no discernible difference in H3K4me1 or
351
H3K27ac occupancy at the risk (C) or protective (T) allele of rs6477612 ( ). Figure 6C 
407
The RNA-seq analysis showed that there were an additional 236 differentially expressed genes in 408 the CRISPRa experiment (adjusted P ≤ 0.10); 128 up-regulated and 108 down-regulated 409 ( Supplementary Table 9 ). Importantly, CRISPRa of the psoriasis-implicated enhancer in this 
415
Confirming the importance of KLF4 in skin cells, and validating previous findings of differential 416 gene expression with KLF4 stimulation, differential genes also included EREG (an epidermal growth Table 9 ).
421
The up-regulated genes were enriched in several biological pathways according to the GAGE 422 analysis, of which the most significant related to RNA processing ( Supplementary Table 10 ).
423
According to the STRING database, differential genes were enriched in a number of relevant 424 pathways including apoptosis and response to cell stress, emphasising the role that KLF4 plays in cell 425 cycle regulation and supporting previous findings demonstrating that over-expressing KLF4 leads to 426 G1/S cell cycle arrest (Chen et al., 2001) ( Supplementary Table 11 ).
427
Discussion 428
Genetic predisposition is the largest known risk factor for psoriasis. The GWAS era has provided 429 a wealth of genetic loci associated with psoriasis, and yet if we are to exploit these data fully, for , 2013 , , Simeonov et al., 2017 . Here, we have combined these technologies for the first time 435 focused on investigation into the functional genomics of psoriasis.
436
Our study provides findings that are complementary to previously published data. For example, 
457
The CRISPRa experiment showed that the psoriasis-associated enhancers predominantly 458 affected KLF4 expression, but there was a small but significant effect also on the expression of 459 25 IKBKAP; a gene previously implicated in NFκB signalling (Cohen et al., 1998) . This is perhaps not 460 surprising, since the CHi-C data suggested that the chromatin conformation in 9q31 would bring the 461 psoriasis-associated enhancers into close proximity with the genes to the telomeric side of the gene 462 desert. The RNA-seq experiment confirmed an upregulation of IKBKAP, indicating that these 463 enhancers, and maybe other GWAS implicated regulatory regions, may have multiple downstream 464 effects.
465
In conclusion, we provide evidence as to gene targets in psoriasis risk loci, supporting assigned 466 candidates and in some regions suggesting novel candidates. We also focus on a specific risk locus 467 and, by moving from associated variants to gene, cell type mechanism and pathway, we My-La cells were crosslinked for 10 minutes in 1% (ChIP, HiChIP) or 2% (CHi-C, 3C) formaldehyde.
487
Crosslinking reactions were quenched with 0.135M glycine.
488
Lenti-X 293T cells (Takara Biosciences) were used for lentivirus production. They were cultured 489 in DMEM high-glucose supplemented with 10% FBS and penicillin streptomycin (final concentration 490 100 U penicillin, 0.1 mg streptomycin/ml). 491
Capture Hi-C 492
For CHi-C, RNA baits were designed to target all known non-MHC psoriasis risk loci, defined by 493 one or more independent SNPs associated with psoriasis in GWAS ( Supplementary Table 1 ). The 494 total number of SNPs included was 107 (59 associated with Europeans, 42 with Chinese, and 6 495 associated with both European and Chinese cohorts) corresponding with 68 loci. The baits were 496 selected to target HindIII fragments that overlapped with the linkage disequilibrium (LD) block in 497 each locus, defined by SNPs in r 2 > 0.8 with the lead SNP (1000 Genomes Phase 3 release, European).
498
Due to sequence restraints, baits could not be designed for the 1p36.11 (rs7552167, rs4649203) 499 (Cheng et al., 2014 , Tsoi et al., 2012 and 1q31.1 (rs10789285) (Tsoi et al., 2015) loci; therefore in 500 total there were 104 SNPs corresponding with 66 psoriasis risk loci in the final capture library (907 501 HindIII fragments).
502
The psoriasis baits were combined with a capture library targeting multiple GWAS loci across 503 several immune-mediated diseases: juvenile idiopathic arthritis, asthma, psoriatic arthritis, 504 rheumatoid arthritis and systemic sclerosis. The majority of these baits were included in our 505 previous region CHi-C experiment (Martin et al., 2015) ; results from these loci are not described in 506 27 the present study. Each 120 bp bait was targeted to within 400 bp of a HindIII fragment end, 507 comprised 25-65% GC content and contained fewer than three unknown bases. The baits were 508 synthesised by Agilent Technologies.
509
CHi-C libraries were generated in biological duplicate for My-La and HaCaT (unstimulated or 510 stimulated) cells according to previously described protocols (Dryden et al., 2014 , Martin et al., 511 2015 ; see Supplementary Methods. Briefly, 50 million crosslinked cells were lysed and the 512 chromatin digested with HindIII, followed by biotinylation and in-nucleus ligation. Crosslinks were 513 reversed, the DNA was purified and biotin-streptavidin pulldown was used to enrich for ligation 514 sites. The libraries were amplified and capture was performed using the RNA baits described above 515 using the SureSelect reagents and protocol (Agilent). Following a second amplification the libraries 516 were sequenced using paired-end Illumina SBS technology (see Supplementary Methods for details).
517
CHi-C sequence data were processed through the Hi-C User Pipeline (HiCUP) v0.5.8 (Wingett et   518 al., 2015) . For each cell type, the two biological replicates were simultaneously run through 519 CHiCAGO v1.1.8 (Cairns et al., 2016) in R v3.3.0 and significant interactions were called with a score 520 threshold of 5. Subsequently, the significant interactions were restricted to those between loci on 521 the same chromosome (cis). BEDTools v2.17.0 (Quinlan, 2014) was used to detect interactions 522 between psoriasis-associated fragments and gene promoters, defined by fragments covering regions 523 within 500 bp of transcription start sites (Ensembl release 75; GRCh37). CHi-C interactions were 524 visualised using the WashU Epigenome Browser (Zhou et al., 2013) .
525
Hi-C 526
For each cell type, a pre-CHi-C library was generated (see Supplementary Methods) . Hi-C 
542
Methods for details).
543
Sequencing data for the HiChIP libraries was filtered and the adapters were removed using fastp 544 v0.19.4. The reads were then mapped to the GRCh38 genome with Hi-C Pro v2.11.0, using default 545 settings. Long-range interactions were called using hichipper v0.7.3 (Lareau and Aryee, 2018). The 546 anchors were called using the self-circle and dangling end reads corresponding to each sample. The 547 remainder of the settings were left default. Interactions were filtered by FDR < 0.10 and a minimum 548 of 5 reads. The interactions were filtered to those originating from the H3K27ac peak on the KLF4 549 promoter before being uploaded for visualisation on the WashU Epigenome Browser (Zhou et al., 550 2013). H3K27ac ChIP-seq tracks were generated using the self-circle and dangling end reads from 551 the libraries and extended for 147 bp. The datasets were scaled according to read depth before 552 being uploaded for visualisation to the WashU Epigenome Browser (Zhou et al., 2013) .
553
To compare H3K27ac signal in shared peaks between unstimulated and stimulated HaCaT cells in 554 9q31, genome-wide anchors reported from hichipper were first combined to produce a merged peak 555 29 set. Then the signal from the two conditions was intersected on the peaks using BEDTools map 556 function and the mean signal for each peak was reported for each condition. The resulting values 557 were imported in R and normalized using DESeq2 estimate size factors function (Love et al., 2014) .
558
The normalized counts for peaks within the 9q31 TAD (chr9:110, 202, 602, 280) were 559 compared between the two conditions using a Wilcoxon matched-pairs signed rank test in GraphPad 560 Prism. (Anders et al., 2015) . Count matrixes were analysed in R 3.5.1 and normalisation and differential 572 expression analysis was conducted using DESeq2 v1.22.2. Differentially expressed genes were called 573 with an adjusted P value of 0.10 (FDR 10%). Gene set enrichment Pathway analysis was performed 574 using GAGE v2.32.1 (Luo et al., 2009) using "normal" shrinked log fold changes from DESeq2. For 575 detection of expressed genes in the cell lines, we considered RNA-seq counts greater than 1 in at 576 least one of the sequenced samples.
561
RNA-seq
571
577
Functional annotation in 9q31
578 SNPs in LD (r 2 >0.8) with the lead SNP rs10979182 were examined for their intersection with 579 ENCODE data for histone marks, transcription factor binding sites and DNase hypersensitivity.
30
RegulomeDB v1.1 (Boyle et al., 2012) was used to rank the SNPs based on likely regulatory function.
581
The SNPs were also assessed using Haploreg v4.1 (Ward and Kellis, 2012), which includes expression 582 quantitative trait loci (eQTL) data from several studies including GTEx (Lonsdale et al., 2013) and 583 GEUVADIS (Lappalainen et al., 2013) .
584
3C-qPCR in 9q31
585 3C libraries were generated in biological triplicate as previously described (Naumova et al., 586 2012). Briefly, 20-30 million crosslinked cells were lysed, digested, ligated and purified as in the 587 initial Hi-C steps, omitting biotinylation. Control libraries were constructed using bacterial artificial 588 chromosome (BAC) clones as described by (Naumova et al., 2012) . Eleven minimally-overlapping 589 BAC sequences were selected to span the 9q31 locus (chr9:110168556-111889073, hg19); see 590 Supplementary Methods.
591
qPCR was carried out using SYBR Green or TaqMan technology to determine interaction 592 frequencies in the 9q31 locus. Relative interaction frequencies were calculated using the BAC curve 593 and normalised to a short-range control. Significant interactions (P < 0.05) were detected using one-594 way ANOVA in GraphPad Prism with Dunnett's or Tukey's test for multiple comparisons.
595
ChIP-qPCR in 9q31 596
Chromatin immunoprecipitation (ChIP) libraries were generated as previously described 597 (McGovern et al., 2016) ; see Supplementary Methods. Briefly, 10 million cross-linked cells were 598 lysed and the chromatin was fragmented and immunoprecipitated with antibodies for H3K4me1 599 (Abcam ab8895) or H3K27ac (Abcam ab4729). ChIP enrichment was measured at loci of interest by 600 qPCR using SYBR Green or TaqMan technology. The data were normalised by calculating the 601 percentage of total chromatin that was immunoprecipitated in comparison with an input sample.
602
For SYBR experiments, primers were designed using Primer3 (http://primer3.ut.ee/) 603 (Untergasser et al., 2012) to target regions of 100-200 bp encompassing enhancers in 9q31 31
